Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

Jyotsna Ghosh; Sam Kant; Isabel Villegas Kastner; Duvuru Geetha

doi:10.1016/j.ekir.2021.12.010

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

Jyotsna Ghosh, Sam Kant, Isabel Villegas Kastner, Duvuru Geetha

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	651-652
Number of pages	2
Journal	Kidney International Reports
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/j.ekir.2021.12.010
State	Published - Mar 2022

ASJC Scopus subject areas

Nephrology

Access to Document

10.1016/j.ekir.2021.12.010

Cite this

@article{5e52c9ce9ada45509db2a0c71d6278d0,

title = "Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis",

author = "Jyotsna Ghosh and Sam Kant and Kastner, {Isabel Villegas} and Duvuru Geetha",

note = "Funding Information: DG is supported by the Jerome L. Greene Scholar award. ",

year = "2022",

month = mar,

doi = "10.1016/j.ekir.2021.12.010",

language = "English (US)",

volume = "7",

pages = "651--652",

journal = "Kidney International Reports",

issn = "2468-0249",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

AU - Ghosh, Jyotsna

AU - Kant, Sam

AU - Kastner, Isabel Villegas

AU - Geetha, Duvuru

N1 - Funding Information: DG is supported by the Jerome L. Greene Scholar award.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85124754105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124754105&partnerID=8YFLogxK

U2 - 10.1016/j.ekir.2021.12.010

DO - 10.1016/j.ekir.2021.12.010

M3 - Letter

C2 - 34926873

AN - SCOPUS:85124754105

SN - 2468-0249

VL - 7

SP - 651

EP - 652

JO - Kidney International Reports

JF - Kidney International Reports

IS - 3

ER -

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this